Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

A new review article published in Genes & Diseases explores the intricate relationship between non-coding RNAs and oxidative stress in cancer progression shedding new light on the mechanisms that ...

The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...

Huntley Street will air a special national broadcast, Strong & Free: A National Movement for Faith, Unity, and Action, highlighting the role of faith in strengthening Canada's social fabric. The ...

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...

Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the retirement of Dr. Phillip A. Sharp, Ph.D., from the Company’s Board of Directors, effective as ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were still alive, most without disease ...

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...